Fabiola Del Greco M1, Luisa Foco1, Irene Pichler1, Philipp Eller2, Kathrin Eller2, Beben Benyamin3,4, John B Whitfield3, Peter P Pramstaller1, John R Thompson5, Cristian Pattaro1, Cosetta Minelli6. 1. Center for Biomedicine, European Academy of Bolzano/Bozen (EURAC), affiliated with the University of Lübeck, Via Galvani 31, Bolzano, Italy. 2. Medical University of Graz, Graz, Austria. 3. QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 4. Queensland Brain Institute, University of Queensland, Brisbane, Queensland, Australia 5. Department of Health Sciences, University of Leicester, Leicester, UK. 6. Population Health and Occupational Disease, National Heart and Lung Institute, Imperial College, Emmanuel Kaye Building, 1 Manresa Road, London, UK.
Abstract
Background: Iron depletion is a known consequence of chronic kidney disease (CKD), but there is contradicting epidemiological evidence on whether iron itself affects kidney function and whether its effect is protective or detrimental in the general population. While epidemiological studies tend to be affected by confounding and reverse causation, Mendelian randomization (MR) can provide unconfounded estimates of causal effects by using genes as instruments. Methods: We performed an MR study of the effect of serum iron levels on estimated glomerular filtration rate (eGFR), using genetic variants known to be associated with iron. MR estimates of the effect of iron on eGFR were derived based on the association of each variant with iron and eGFR from two large genome-wide meta-analyses on 48 978 and 74 354 individuals. We performed a similar MR analysis for ferritin, which measures iron stored in the body, using variants associated with ferritin. Results: A combined MR estimate across all variants showed a 1.3% increase in eGFR per standard deviation increase in iron (95% confidence interval 0.4–2.1%; P = 0.004). The results for ferritin were consistent with those for iron. Secondary MR analyses of the effects of iron and ferritin on CKD did not show significant associations but had very low statistical power. Conclusions: Our study suggests a protective effect of iron on kidney function in the general population. Further research is required to confirm this causal association, investigate it in study populations at higher risk of CKD and explore its underlying mechanism of action.
RCT Entities:
Background: Iron depletion is a known consequence of chronic kidney disease (CKD), but there is contradicting epidemiological evidence on whether iron itself affects kidney function and whether its effect is protective or detrimental in the general population. While epidemiological studies tend to be affected by confounding and reverse causation, Mendelian randomization (MR) can provide unconfounded estimates of causal effects by using genes as instruments. Methods: We performed an MR study of the effect of serum iron levels on estimated glomerular filtration rate (eGFR), using genetic variants known to be associated with iron. MR estimates of the effect of iron on eGFR were derived based on the association of each variant with iron and eGFR from two large genome-wide meta-analyses on 48 978 and 74 354 individuals. We performed a similar MR analysis for ferritin, which measures iron stored in the body, using variants associated with ferritin. Results: A combined MR estimate across all variants showed a 1.3% increase in eGFR per standard deviation increase in iron (95% confidence interval 0.4–2.1%; P = 0.004). The results for ferritin were consistent with those for iron. Secondary MR analyses of the effects of iron and ferritin on CKD did not show significant associations but had very low statistical power. Conclusions: Our study suggests a protective effect of iron on kidney function in the general population. Further research is required to confirm this causal association, investigate it in study populations at higher risk of CKD and explore its underlying mechanism of action.
Authors: Jennifer Sjaarda; Hertzel C Gerstein; Salim Yusuf; Darin Treleaven; Michael Walsh; Johannes F E Mann; Sibylle Hess; Guillaume Paré Journal: J Am Soc Nephrol Date: 2018-03-06 Impact factor: 10.121
Authors: Vickie S Braithwaite; Martin N Mwangi; Kerry S Jones; Ayşe Y Demir; Ann Prentice; Andrew M Prentice; Pauline E A Andang'o; Hans Verhoef Journal: Am J Clin Nutr Date: 2021-05-08 Impact factor: 7.045
Authors: Diego Martin-Sanchez; Angel Gallegos-Villalobos; Miguel Fontecha-Barriuso; Susana Carrasco; Maria Dolores Sanchez-Niño; Francisco J Lopez-Hernandez; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz; Ana Belén Sanz Journal: Sci Rep Date: 2017-01-31 Impact factor: 4.379
Authors: Tahzeeb Fatima; Cushla McKinney; Tanya J Major; Lisa K Stamp; Nicola Dalbeth; Cory Iverson; Tony R Merriman; Jeffrey N Miner Journal: Arthritis Res Ther Date: 2018-08-15 Impact factor: 5.156
Authors: Ridha I S Alnuwaysir; Martijn F Hoes; Dirk J van Veldhuisen; Peter van der Meer; Niels Grote Beverborg Journal: J Clin Med Date: 2021-12-27 Impact factor: 4.964